L3Harris Technologies is the sixth-largest US defense contractor by sales. It formed in 2019 from the merger of L3 Technologies, a decentralized and acquisitive maker of sensors, and Harris, a sensor ...
L3Harris Technologies (NYSE: LHX) reported fourth quarter 2024 diluted EPS of $2.37 on fourth quarter 2024 revenue of $5.5 billion. Fourth quarter 2024 non-GAAP diluted EPS was $3.47. Fourth quarter ...
L3Harris Technologies is a multi-domain aerospace and defense specialist with strong growth prospects. Read why I think LHX ...
LHX's total revenues in the fourth quarter of 2024 beat the Zacks Consensus Estimate by 0.3%. The top line also increases 3.4 ...
L3Harris Technologies, Inc. LHX is slated to report fourth-quarter 2024 results on Jan. 30, 2025, before market open. See the Zacks Earnings Calendar to stay ahead of market-making news. L3Harris has ...
A piece of land owned by the holding company for Aerojet Rocketdyne Inc. has hit the market — but in a smaller piece than in the past. A piece of land owned by the holding company for Aerojet ...
Apple’s recent success with the Vision Pro headset and Google’s rapid strides in AI revived the company’s interest enough to ...
As Chief Technology Officer, Beckett will be responsible for leading the Velo3D Research and Development and Informational Technology organizations as well as oversee the implementation of advanced ...
Brings More Than 25 Years of Experience in Next Generation Hardware and Software Technology Development and Deployment in the Additive Manufacturing and Semiconductor ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
A lot of the products we use to treat redness and rosacea are similar, however, so while those on this list are formulated for skin with rosacea, they can also help skin that’s prone to redness.
Search for a state or federal candidate to see the donors and industries that support them.